How post-market studies move an Active C product from placebo comparison to provider recommendation.
Many OTC drugs are used by the general population at the recommendation of their providers. Several prescription drugs have become OTC drugs as post-market studies prove efficacy and safety for the general public without the need for provider supervision.
Post-approval studies target two tiers of research that eventually result in provider recommendation of an OTC product when studies prove superior efficacy compared to a placebo form, and superior efficacy compared to the market leader.
Study participants with a specific medical condition are recruited and randomized into control and study groups.
The study group receives the Active C patch; the control group receives a placebo patch. Both patches appear identical.
Neither the study participant nor the investigator is aware of the identity of the patches.
Participants journal their symptoms for the duration of the study; investigators document clinical progress for wound-healing time studies.
Study participants with a specific medical condition are recruited and randomized into study and control groups.
The study group receives Active C patches for treatment of their condition; the control group receives the leading market product.
All participants journal their symptoms for symptom-control studies.
Investigators document healing progress for wound-healing time studies.
Publication Channels: publication in scientific and medical journals depends on the disease studied and the type of Active C patch used. Potential journals include technology journals covering rheumatology and arthritis, pain management, and dermatology. Articles for publication can take the form of peer review, editorial, case presentation and review article formats.
